RADNOR, Pa., April 7, 2025 /PRNewswire/ — CIFC Asset Management LLC and its affiliates (collectively, “CIFC”) one of the leading providers of financing solutions to middle market companies, provided a senior secured credit facility to support the refinancing of Uniloy, Inc. (“Uniloy” or the “Company”). Uniloy is a portfolio company of Cyprium Partners and Osgood… Continue reading CIFC Supports Refinancing of Uniloy, Inc.
Tag: M and A
Desay Battery Unveils Latest Energy Storage Solutions at Middle East Energy Dubai 2025
HUIZHOU, China, April 7, 2025 /PRNewswire/ — Desay Battery, a pioneer in energy storage, presented its newest self-developed products and solutions at Middle East Energy Dubai 2025, the Middle East’s most influential exhibition for power and renewable energy. The participation underscored the company’s commitment to advancing sustainable energy technologies in the region. Continue Reading Dubai_invitation_2… Continue reading Desay Battery Unveils Latest Energy Storage Solutions at Middle East Energy Dubai 2025
Desay Battery Unveils Latest Energy Storage Solutions at Middle East Energy Dubai 2025
HUIZHOU, China, April 7, 2025 /PRNewswire/ — Desay Battery, a pioneer in energy storage, presented its newest self-developed products and solutions at Middle East Energy Dubai 2025, the Middle East’s most influential exhibition for power and renewable energy. The participation underscored the company’s commitment to advancing sustainable energy technologies in the region. Continue Reading The… Continue reading Desay Battery Unveils Latest Energy Storage Solutions at Middle East Energy Dubai 2025
Lenire Supports Veterans by Sponsoring Hearoes Tour
Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour. Lenire is a treatment option for 3.2m veterans living with tinnitus. CHICAGO, April 7, 2025 /PRNewswire/ — Lenire, the first and only FDA Approved tinnitus treatment device of its kind, is proud to sponsor the 10th Annual LexCare Hearing Foundation Hearoes Tour to raise… Continue reading Lenire Supports Veterans by Sponsoring Hearoes Tour
SS&C Strengthens Middle East Business with Saudi Arabia Office
WINDSOR, Conn., April 7, 2025 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced an expansion of its global footprint by opening a new office in Riyadh, Saudi Arabia. The office will enable SS&C to forge new relationships and work more closely with the Capital Markets Authority and the Saudi Arabian Monetary Agency. SS&C’s Middle East business serves 850… Continue reading SS&C Strengthens Middle East Business with Saudi Arabia Office
Advanced Therapies Europe 2025 unveils a reimagined, high-impact format: capped at 500, curated for connection
BARCELONA, Spain, April 7, 2025 /PRNewswire/ — Advanced Therapies Europe arrives in Barcelona for the first time, taking place from 2-4 September 2025 at the Hotel Arts, Ritz-Carlton. With a bold new focus, this year’s edition introduces a reimagined format: an exclusive, in-person experience, capped at just 500 attendees. With attendance strictly limited, the emphasis is… Continue reading Advanced Therapies Europe 2025 unveils a reimagined, high-impact format: capped at 500, curated for connection
FIECON Joins Herspiegel to Expand Global Life Science Commercialization Services
Strengthening Market Access and Health Economics Capabilities to Support Global Biopharma YARDLEY, Pa. and LONDON, April 7, 2025 /PRNewswire/ — Herspiegel, a world leader in pharmaceutical and biotech commercialization services, continues its strategic expansion by joining forces with FIECON, Europe’s leading health economics and market access consultancy firm. This strategic integration expands Herspiegel’s proven market… Continue reading FIECON Joins Herspiegel to Expand Global Life Science Commercialization Services
Immunity Pharma Presents New Data Supporting the Efficacy of IPL344 in ALS
Results from phase 2a trial in ALS patients were published in Muscle and Nerve. Statistically significant 58% to 64% slower ALSFRS-R progression rate in IPL344-treated patients compared to the matched PRO-ACT records. NfL was reduced by 27% for patients treated for at least two months. Unadjusted median survival for participants in the IPL344 group was… Continue reading Immunity Pharma Presents New Data Supporting the Efficacy of IPL344 in ALS
Temu Strengthens Commitment to Quality Assurance with Eurofins Consumer Products Testing Partnership
PARIS, April 7, 2025 /PRNewswire/ — Temu, the international e-commerce platform, is strengthening its product safety and compliance measures through a partnership with Eurofins Consumer Product Testing and Eurofins Assurance, leading global providers of testing, inspection, and certification services. This collaboration aims to support transparency in Temu’s product safety processes, enhance quality control and ensure… Continue reading Temu Strengthens Commitment to Quality Assurance with Eurofins Consumer Products Testing Partnership
Paratus: Transactions Made Under Share Buyback Program
HAMILTON, Bermuda, April 7, 2025 /PRNewswire/ — Reference is made to the stock exchange announcement made by Paratus Energy Services Ltd. (ticker “PLSV”) (“Paratus” or the “Company”) on April 2, 2025 regarding the initiation of a repurchase of up to 1,600,000 shares by way of open market transactions on the Euronext Oslo Børs (the “Buyback”), pursuant… Continue reading Paratus: Transactions Made Under Share Buyback Program